deltatrials
Completed PHASE3 INTERVENTIONAL NCT00272805

Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg

Prospective, Randomized, Controlled Assessment of Once-Daily Controlled Release COREG CR vs Twice-Daily COREG Immediate Release(IR)on Measures of Compliance and Quality of Life in Patients With Heart Failure and Left Ventricular Systolic Dysfunction

Sponsor: Cardiovascular Clinical Sciences Inc

Interventions carvedilol
Updated 7 times since 2017 Last updated: Feb 15, 2013 Started: Oct 31, 2005 Primary completion: Jul 31, 2006 Completion: Jul 31, 2006
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Chronic Heart Failure and is currently completed. Cardiovascular Clinical Sciences Inc leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotCompleted~Jan 2025 – present · 18 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Jan 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Jan 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

Show 2 earlier versions
  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cardiovascular Clinical Sciences Inc
  • GlaxoSmithKline
Data source: Cardiovascular Clinical Sciences Inc

For direct contact, visit the study record on ClinicalTrials.gov .